BNLB Share Price Performance
€80.00
0.00 (0.00%)
Price €80.00
Share Price€80.00
Brainlab SE Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
BNLB Community Narratives
There are no narratives available yet.
Recent BNLB News & Updates
No updates
Brainlab SE Key Details
Last Reported Earnings
n/a
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Brainlab SE Competitors
Snowflake Analysis
About BNLB
- Founded
- 1989
- Employees
- n/a
- CEO
- WebsiteView website
Brainlab AG develops, manufactures, and markets software-driven medical technology for invasive medical treatments worldwide. It offers various software and components for image-guided surgery and radiotherapy, as well as provides integrated systems for stereotactic radiosurgery. The company’s products are used in the areas of neurosurgery; orthopedics; ear, nose, and throat; radiotherapy; spine and trauma; and IORS. Brainlab AG has strategic partnership with Biomet, Inc. The company was founded in 1989 and is headquartered in Munich, Germany with additional offices worldwide.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
German Market Performance
- 7 Days: -1.0%
- 3 Months: -1.6%
- 1 Year: 12.4%
- Year to Date: 12.1%
Over the last 7 days, the market has dropped 1.0%, driven by pullbacks in the Consumer Discretionary and Industrials sectors of 4.0% and 1.8%, respectively. In contrast to the last week, the market is actually up 12% over the past year. Earnings are forecast to grow by 17% annually. Market details ›